Skip to content

ACCELERATING THE NEXT GENERATION OF PROCESS DEVELOPMENT & MANUFACTURING FOR THE UK

3-4 November 2026 Radisson Blu Hotel, London Heathrow, London, United Kingdom
Co-located Events
BFL2026_logo_square_white 2
BioSourceEurope2026 logo white

KEY THEMES & TOPICS

Biologics Manufacturing Strategy
Next-Gen Upstream Processing
Downstream Purification Optimisation
AI & Data Analytics for Process Robustness
Building Future-Ready Biomanufacturing Capacity
Supply Chain Resilience and Logistics
WHO
 For Site Heads, Manufacturing VPs, and Engineering Directorsbased in the UK & Ireland, or global firms investing in the region's capacity. 
WHAT
  The premier operational gathering for the UK/IE biopharma hub, focusing on MHRA regulatory innovation, digital transformation, and capacity expansion. 
WHY
 To leverage the UK’s unique Point-of-Care framework and Ireland’s massive infrastructure growth to build a "Western Launchpad" for global biologics.  
icons cgw welcome_1
0 +

Senior Attendees

Meet a concentrated audience of Site Heads, Manufacturing VPs, and Engineering Directors from the UK & Ireland’s top biopharma hubs and investment projects. 
icons cgw welcome-02
0 +

Expert Speakers

Hear from world-class leaders in regulatory innovation (MHRA), facility design, digital manufacturing, and workforce development for the next generation of biologics. 
bwd2026-company-ezgifcom-speed.bb78342dfc94
0 +

Companies Represented

A gathering representing major global pharma investors, UK innovators, leading engineering firms, and technology providers building the future of British bioproduction. 

AGENDA AT A GLANCE

Day 1 | 3 November 2026
Biologics Manufacturing Strategy
Networking Break
Optimising CDMO Partnerships and Technical Transfer
 Spotlight: ADC Outsourcing Excellence
Lunch
Next-Gen Upstream Processing
Downstream Purification Optimisation
Networking Break
Strategies For Selecting & Managing CDMOs
Industry Roundtables
End of Conference Day 1
Day 2 | 4 November 2026
Managing Quality Oversight Across External Manufacturing Networks
AI & Data Analytics for Process Robustness
Building Future-Ready Biomanufacturing Capacity
AI Driven Manufacturing
Supply Chain Resilience and Logistics
Closing Panel Discussion – Future of European Biomanufacturing + Formulation
End of Conference
DAY 1
3 November 2026
VIEW DAY 1 VIEW DAY 2
08:00 Registration & Coffee
08:50

Chairman’s Welcome Address

Dr Uwe Gottschalk Operating Partner, Keensight Capital, France
Biologics Manufacturing Strategy
09:00

A Quality Perspective on Building an AI Strategy That Outlives the Technology

  • Why most AI efforts stall: chasing each new capability produces a portfolio of orphans, while a multi-year platform bet delivers nothing until it is finished — and is often obsolete before it lands.
  • Defining an integrated strategy that survives an accelerating technology landscape — anchored on your processes and your data, so the strategy outlives the tools underneath it.
  • Proving it in a live GMP environment: structuring deviation information at the point of capture to cut documentation time today while making quality data usable tomorrow.
  • Compounding the return: connecting deviations, CAPAs, controlled documents, audit findings and published inspection outcomes so patterns surface across products, sites and years.
  • Holding the line under pressure: validation, grounding and human-in-the-loop designed in from day one, and how to answer the "why aren't we using the newest thing?" question. 
Ian Baldacchino Vice President, Global Head of Internal Manufacturing Quality, UCB, Belgium Mathias Van den Borre Head of Digital Innovation, Global Quality, UCB, Belgium
09:25

Topic - TBC

Solution Provider
Inprocess LSP
09:50

Supply Chain - Intelligence to Increase the Volume & Velocity of Decisions (TBC)

  • Leveraging real-time data analytics to improve visibility across end-to-end biologics supply networks
  • Using AI-driven forecasting to accelerate decision-making on demand shifts, capacity, and inventory
  • Integrating cross-functional data streams to reduce bottlenecks and improve responsiveness
  • Enhancing risk detection and scenario planning to support faster, more confident supply chain decisions

 

Niveth Richard Supply Chain Decision Intelligence Lead, GSK, UK
10:15

Topic- TBC

Dirk Boehm Site Head DS Penzberg (VP), Roche, Germany
10:40 Networking Break
Optimising CDMO Partnerships and Technical Transfe
11:40

Building Scalable and Robust Biologics Platforms Through Integrated Process and Formulation Development

  • Building a trusted CMC data foundation as the backbone for faster, more reliable transfers

  • Connecting AI, automation and digital tools across the end-to-end technology-transfer process

  • Translating digital insights into manufacturing readiness, reduced risk and fewer pre-PPQ runs

  • Establishing measurable standards for value tracking, acceleration and continuous improvement

  • Scaling a repeatable approach across products, modalities, sites and partnerships

Filippo Ramondelli Associate Director - TT & Project Management Lead, Takeda, Italy
11:35

Spotlight: ADC Outsourcing Excellence

Solution Provider
BSP Pharmaceuticals
12:00

De-Risking Tech Transfer and Scale-Up with CDMOs

  • Managing successful tech transfer across complex manufacturing processes
  • Reducing scale-up risks while maintaining product quality and consistency
  • Improving communication and operational alignment between sponsors and CDMOs
  • Ensuring supply continuity and manufacturing readiness for commercial demand
Anthony Beaney Principal Scientist, Lonza Biologics, UK
12:25

Strategic Oversight of ADC External Manufacturing: Strengthening Sponsor–CDMO Collaboration from Tech Transfer to Commercial Supply

  • Managing successful tech transfer from development to commercial supply
  • Strengthening sponsor–CDMO alignment across ADC manufacturing programs
  • Ensuring quality and supply continuity across external manufacturing networks
  • Improving operational visibility and governance within complex ADC supply chains
12:50 Lunch
Next-Gen Upstream Processing: Intensification & Perfusion
13:50

Unlocking Biologics Manufacturing Potential: Case Studies in Data Science Applications

  • Applying data science to optimize upstream and downstream process performance and reduce variability
  • Using advanced analytics to identify root causes of batch deviations and improve yield consistency
  • Leveraging predictive models to enhance process control, scale-up success, and tech transfer efficiency
  • Demonstrating real-world case studies where data-driven insights improved cost, quality, and time-to-market
Shyam Panjwani Principal Biotech Data Scientist | CMC Statistician | Biologics Manufacturing, Bayer, USA
14:15

Topic- TBC

Michael Palige Process Development & CMC Lead, Takeda, Austria
Downstream Purification Optimisation
14:40

AI-Enabled Downstream Purification Optimisation: Improving Yield, Purity & Process Robustness

  • Optimising chromatography and filtration steps using data-driven process modelling and real-time monitoring
  • Reducing product loss and impurity breakthrough through improved control of critical process parameters
  • Integrating PAT and advanced analytics to enable faster troubleshooting and cycle time reduction
  • Enhancing scalability and robustness of purification processes from lab to commercial manufacturing
Gavin Wild Head of Early Process Sciences, UCB, UK
15:05 Networking Break
Strategies for Selecting & Managing CDMOs
15:30

Managing CDMO Partnerships Across Formulation & Supply Networks (TBC)

  • Selecting the right CDMO partners for formulation development, manufacturing, and commercial supply.
  • Establishing governance models that drive performance, transparency, and long-term collaboration.
  • Managing supply chain risks, capacity constraints, and business continuity across external networks.
  • Using performance metrics and operational reviews to ensure quality, reliability, and on-time delivery.
Karen O'Hanlon Chief Operating Officer, StablePharma, UK
15:55

Choosing the Right Outsourcing Partner: From Payload to Fill-Finish

  • Evaluating CDMO capabilities across the full manufacturing workflow
  • Strengthening collaboration and oversight across multi-partner supply chains
Abisola (Abi) Kuforiji Associate Director-External Manufacturing -Operations lead (EMEA), MSD, Switzerland
16:20
Roundtable Discussion
 From Pilot to Scale: What Does Successful AI Adoption Really Look Like in GMP Operations?  
Ian Baldacchino Vice President, Global Head of Internal Manufacturing Quality, UCB, Belgium Mathias Van den Borre Head of Digital Innovation, Global Quality, UCB, Belgium
Is Your Data Ready for AI? Building the Foundations for Scalable ML (TBC)
Niveth Richard Supply Chain Decision Intelligence Lead, GSK, UK
Scaling Biologics Manufacturing for Future Demand (TBC)
Dirk Boehm Site Head DS Penzberg (VP), Roche, Germany
Maximising drug product manufacturing
Alexander Hempel Manager Drug Substance Manufacturing, Avethera, Germany
TBC
Valerie Chambard-Benalleg Vaccine Manufacturing Supply Chain Lead, CEPI, UK
 Outsourcing Decisions: In-House Capabilities vs. External Partners (TBC) 
Julia Hinteramskogler Head of Technical Development, Elaris, Austria
 Building High-Trust Sponsor-CDMO Relationships 
Franz Schnetzinger VP / Head PAD & QC, AAVantgarde Bio, UK
17:20 Key Takeaways
17:30 Cocktail Reception
18:00 End of Conference Day 1
DAY 2
4 November 2026
VIEW DAY 1 VIEW DAY 2
08:00 Registration & Coffee
08:50

Chairman’s Welcome Address

Managing Quality Oversight Across External Manufacturing Network
09:00

Building Robust Quality Governance Across Global CDMO Networks

  • Establishing effective quality governance frameworks across global CDMO networks
  • Strengthening sponsor–CDMO collaboration through clear accountability, communication, and oversight
  • Implementing risk-based approaches to supplier management, audits, and quality performance monitoring
  • Maintaining inspection readiness and consistent GMP compliance across outsourced manufacturing operations
Marcelo Castro Senior Director, Global Biopharma External Supply Operations Quality, Pfizer, Ireland
09:25

Enhancing Visibility and Control in External Manufacturing Quality Systems

  • Strengthening quality oversight across complex external manufacturing networks
  • Improving real-time visibility and risk management within supplier quality systems
  • Aligning sponsor–CDMO quality expectations and governance frameworks
  • Leveraging digital tools and data analytics to enhance compliance and operational control
Cathal Gallagher Senior Director-Head of Quality, External Operations EU, Takeda, Ireland
09:50

Speed to Clinic: Tech Transfer and Phase I Manufacturing in Under 6 Months 

Solution Provider
Dr Ashwinkumar V Meru Head of Global Business Development, Kemwell, India
10:15

Strengthening Quality Oversight Across External Manufacturing Networks

  • Standardising GMP and quality systems across CDMO partners for consistent compliance
  • Using digital QMS tools for real-time deviation tracking and faster resolution
  • Strengthening risk-based audits and supplier qualification across sites
  • Driving continuous improvement through CAPA and shared quality KPIs
Jose Martinez Calderon QA R&D and Commercial Product Development Senior Director, Almirall, Spain
10:40 Networking Break
AI & Data Analytics for Process Robustness
11:10

Data-Driven Biopharma: Integrating Real-World Evidence into Development and Lifecycle Strategy

  • Leveraging real-world evidence (RWE) to complement clinical trial data and strengthen regulatory and payer submissions
  • Integrating diverse data sources to identify patient subgroups, treatment outcomes, and unmet medical needs
  • Using advanced analytics to support lifecycle management, label expansion, and post-market surveillance
  • Enabling faster, more informed decision-making across development, commercialization, and market access strategies
11:35

Single-Cell RNA Sequencing (scRNA-seq) Workflow: From Sample to Insight

  • Isolating and capturing individual cells using microfluidics or droplet-based platforms for high-resolution profiling
  • Performing reverse transcription and library preparation to generate single-cell gene expression datasets
  • Sequencing and processing data through bioinformatics pipelines for quality control and alignment
  • Clustering and interpreting cellular heterogeneity to identify subpopulations and functional states
Dr Aurelien Bunga Senior Scientist, Rinri Therapeutics, UK
12:00

Predicting the Future: Kinetic Modelling for Smarter Stability Decisions Across the Pharmaceutical Lifecycle

  • De-risking early clinical development through accelerated stability prediction with quantified uncertainty
  • Optimising cold chain design and setting evidence-based temperature excursion limits
  • Accelerating shelf -life determination and supporting regulatory submissions with GMP-ready outputs
  • Enabling real-time stability comparability assessment across batches, sites and manufacturing changes
Dr Warren Roche Biostatistician, Argenx, Belgium
12:25 Lunch
Building Future-Ready Biomanufacturing Capacity
13:30

Optimising Strategic Network Design through Make vs Buy Decision Frameworks

  • Evaluating internal vs outsourced manufacturing capabilities
  • Designing flexible and scalable manufacturing networks
  • Balancing cost, control, and speed to market
  • Managing risks across global production and supply networks
Dr John Bridgeman Chief Scientific Officer, ImmunoKey, UK
13:55

Vaccine manufacturing networks in Low- and Middle-Income Countries

  • Strengthening regional vaccine manufacturing capacity and supply resilience in LMICs
  • Building sustainable technology transfer and local manufacturing partnerships
  • Overcoming infrastructure, workforce, and regulatory challenges across emerging markets
  • Enhancing equitable access through scalable and future-ready vaccine manufacturing networks
Vishal Mukund Sonje Senior Vaccine Manufacturing Lead, CEPI, UK
AI Driven Manufacturing
14:15

AI-Driven Manufacturing: From Innovation to Implementation (TBC)

  • Accelerating the adoption of AI across biopharmaceutical manufacturing
  • Overcoming barriers to implementation and organizational readiness
  • Ensuring robust decision-making through data-driven manufacturing strategies
  • Lessons learned from integrating emerging technologies into development and manufacturing
Tejash Shah Senior Director, Biopharm CMC Regulatory Affairs, GSK, UK
Supply Chain Resilience & Logistics
14:40

How to Build a Procurement Consortium in Africa: Building a Model of Aggregated Input Material Sourcing and Procurement

  • Developing collaborative procurement models to strengthen supply chain resilience across African markets
  • Aggregating demand to improve supplier access, purchasing power, and supply continuity
  • Overcoming regulatory, logistical, and stakeholder challenges in multi-country procurement initiatives
  • Lessons learned and best practices for building sustainable public-private procurement partnerships
Valerie Chambard-Benalleg Vaccine Manufacturing Supply Chain Lead, CEPI, UK
15:05
Panel Discussion

The Future of Biopharma Supply Chains – Building Resilience, Agility & Sustainability

Panelists
Brendan Noone Senior Director, Global Supply Chain & Strategy, AstraZeneca, Ireland Dr. Andreea Iftimia-Mander Head of Analytical and Biological Sciences (SCS1), MHRA, UK
15:45 Networking Break
16:00
Panel Discussion

Future of European Biomanufacturing + Formulation

  • Europe’s biomanufacturing future depends on scaling advanced facilities while maintaining high regulatory and quality standards.
  • Strategic investment in automation, digitalisation, and AI will be critical to offset high operating costs.
  • Strengthening local supply chains will improve resilience and reduce dependency on external geographies.
  • Collaboration across academia, industry, and CDMOs will accelerate innovation and capacity expansion.
Panelists
Julia Hinteramskogler Head of Technical Development, Elaris, Austria Syed Saqib Naqvi Supply Chain Digital Lead, Amicus Therapeutics, UK
16:45 Closing Remarks
17:00 End of Conference

MEET THE SPEAKERS

Ridwaan Jhetam BIG PHARMA

Ridwaan Jhetam

Senior Vice President : Head of Worldwide Medical Affairs Hematology
Bristol Myers Squibb
UK
Connect on LinkedIn
Ahmed Abou Khatwa BIG PHARMA

Ahmed Abou Khatwa

Regional Patient Value and Access Director
Takeda
Singapore
Connect on LinkedIn
Dr. Andreea Iftimia-Mander

Dr. Andreea Iftimia-Mander

Head of Analytical and Biological Sciences (SCS1)
MHRA
UK
Connect on LinkedIn
Filippo Ramondelli BIG PHARMA

Filippo Ramondelli

Associate Director - TT & Project Management Lead
Takeda
Italy
Connect on LinkedIn
Marcelo Castro BIG PHARMA

Marcelo Castro

Senior Director, Global Biopharma External Supply Operations Quality
Pfizer
Ireland
Connect on LinkedIn
Paul de Goede BIG PHARMA

Paul de Goede

Principal Scientist Formulation Development
Johnson & Johnson Innovative Medicine
Netherlands
Connect on LinkedIn
Shyam Panjwani BIG PHARMA

Shyam Panjwani

Principal Biotech Data Scientist | CMC Statistician | Biologics Manufacturing
Bayer
USA
Connect on LinkedIn
Tarik Cheema BIG PHARMA

Tarik Cheema

Asset Excellence Lead Pre-Filled Syringes
Roche
Switzerland
Connect on LinkedIn
Marieta Duvnjak BIG PHARMA

Marieta Duvnjak

Head Science & Operations in Analytical Research and Development
Novartis
India
Connect on LinkedIn
Max Corbett BIG PHARMA

Max Corbett

Senior Director, CMC Group Head Biologics and Small Molecule
CSL
Switzerland
Connect on LinkedIn
Sarah Pasqualinotto BIG PHARMA

Sarah Pasqualinotto

External Site Lead, External Operations (Associate Director)
Biogen
Switzerland
Connect on LinkedIn
Brendan Noone BIG PHARMA

Brendan Noone

Senior Director, Global Supply Chain & Strategy
AstraZeneca
Ireland
Connect on LinkedIn
BioUK2026_SPEAKER_Cathal Gallagher-1 BIG PHARMA

Cathal Gallagher

Senior Director-Head of Quality, External Operations EU
Takeda
Ireland
Connect on LinkedIn
BioUK2026_SPEAKER_Abisola (Abi) Kuforiji BIG PHARMA

Abisola (Abi) Kuforiji

Associate Director-External Manufacturing -Operations lead (EMEA)
MSD
Switzerland
Connect on LinkedIn
Sébastien Dasnoy

Sébastien Dasnoy

Principal Scientist, Injectable Formulation Development
UCB
Brussels
Connect on LinkedIn
Ian Baldacchino

Ian Baldacchino

Vice President, Global Head of Internal Manufacturing Quality
UCB
Belgium
Connect on LinkedIn
Jose Martinez Calderon

Jose Martinez Calderon

QA R&D and Commercial Product Development Senior Director
Almirall
Spain
Connect on LinkedIn
Ritupon Gogoi

Ritupon Gogoi

Director, CMC (Biologics Fill-Finish and Drug-Device Combination Products)
Zura Bio
UK
Connect on LinkedIn
Marco Carfagna

Marco Carfagna

Head of Formulation Development & Drug Product Labs
Formycon
Germany
Connect on LinkedIn
Harsha Reddy

Harsha Reddy

Group Lead - Head Upstream Process Development, CMC Bioprocess Lead
Accord BioPharma
UK
Connect on LinkedIn

 Interested in Sharing Your Expertise and Insights? 

Sponsors & Media Partner

Special thanks to our event partners, without whom we would not be able to provide
this networking, learning, and collaborating platform to the community

Looking to partner with us for this event?

EXPECTED AUDIENCE SNAPSHOT
Biopharma (Mid-size & Emerging)
Attendance from

Biopharma (Mid-size & Emerging)

40%
Big Pharma
Attendance from

Big Pharma

25%
CDMO / CMO
Attendance from

CDMO / CMO

15%
Technology / Equipment / Solutions Providers
Attendance from

Technology / Equipment / Solutions Providers

15%
Academia / Research / Government
Attendance from

Academia / Research / Government

5%

Decision Makers

C-Suite / EVP (CEO, COO, CSO)
VP / Global Head / Site Head
Director / Associate Director
Senior Manager / Manager
Business Development

By Geography

BioManuUK2026-map

By Job Function

Manufacturing Operations / Site Leadership
0%
MSAT / Process Development
0%
Engineering / Automation / Digital
0%
Quality / Compliance / Validation
0%
Supply Chain / Planning
0%
Strategy / Continuous Improvement
0%
Target Attendee Companies
Big Pharma
Biopharma
CDMOs

Targeted Attendees List

View Expanded List
SPONSORSHIP OPPORTUNITIES
Who Should Sponsor?

EPCMV Firms

Design and build partners for next-gen facilities.

Bioprocessing Equipment

Vendors of bioreactors, skids, and single-use systems.

Industry 4.0 Providers

Digital Twin, MES, and AI process control solutions.

QMS Software

Platforms for digital quality, data integrity, and remote oversight.

Process Intensification

Perfusion and continuous processing specialists.

Sponsorship_bwd2026_icon__0004

Thought Leadership Speaking

Sponsorship_bwd2026_icon__0003

Panel Participation

Sponsorship_bwd2026_icon__0002

Solution Showcases

Sponsorship_bwd2026_icon__0001

Engagement and Visibility Opportunities

Sponsorship_bwd2026_icon__0006

Branding and Digital Visibility

Sponsorship_bwd2026_icon__0000

Exclusive Networking

TESTIMONIALS
Speaker Headshot BWD2026 Heiner Apeler 2
Dr Heiner Apeler
VP Head of Biologics Development
Bayer Germany

The Biologics and CGT Manufacturing DACH conference 2026 was very well planned and coordinated. It provided high-quality talks for staying up-to-date in our industry and I specifically enjoyed the time for networking.

BioOut2026_SPEAKER_John Bridgeman
John Bridgeman
CSO
Immunokey UK

Thanks for the invite to speak at the event. It was a really enjoyable meeting and a great opportunity to present our work to the community. Identifying key partners for ImmunoKey’s development plan is a critical aspect of getting our therapies to patients; the CGT and Biologics Manufacturing DACH meeting offered us the opportunity to engage with key CDMOs who can help us achieve this goal. 

Speakers_photo_bwd_website_Dennis-Stelljes
Dennis Stelljes
Associate Director, Strategic Sourcing & Procurement, Biologics External Manufacturing
BMS Switzerland

 Just back from an incredible time at the Biologics Manufacturing DACH congress! I have to be honest - as someone in Procurement, some of the deep-dives into Cell & Gene and biologics development were definitely above my scientific capabilities! However, the exchange of knowledge was fantastic, and it was a privilege to learn from such brilliant minds. A true highlight was the fantastic collaboration with Christopher Pawlak (PhD) . I had the privilege of co-hosting a round table with him focused on the impact of tariffs in the biopharma world. Christoph, thank you for the partnership - it was a truly dynamic discussion! 🤝 One of my biggest takeaways is that we have officially entered the era of "The Great Reshoring". We are moving past the days when drug manufacturing decisions were purely scientific; they are now deeply geopolitical. As we discussed in our round table, we can no longer just react to change. We have to treat scenario planning like a muscle that we train constantly to design for volatility. The event really hit home how much our world is changing - from the incredible progress in biologics manufacturing to the AI evolution. I’m excited to see how we can implement these insights to build resilience and benefit BMS biologics manufacturing. Back to my desk, I will start with socializing the learnings with my colleagues. A huge thank you to Drishti G. for the flawless organization and to Noel Murphy for approving the trip and supporting this critical learning opportunity! 

Speaker Headshot BWD2026 Andrew Kelly 2
Dr Andrew Kelly
Director, Manufacturing Technology
BMS Ireland

Really well organised conference with great attendees and high engagement - I was delighted to have taken the time to attend and really enjoyed sharing my thoughts on Accelerating Biologics Pipeline and ensuing discussion. Thank you to all organisers and facilitators 

Speakers_photo_bwd_website_Thomas-Villiger
Dr Thomas Villiger
Professor of Bioprocess Technology
University of Applied Sciences and Arts Northwestern Switzerland FHNW Switzerland

A fantastic deep dive into the DACH region’s CGT landscape. This conference made one thing clear: efficacy is proven, but industrialization is the new frontier. To truly move the needle, we must look beyond the lab and focus on scaling automation, streamlining supply chains, and tackling COGS. The diversity of voices - from large corporations, to tech suppliers and academic pioneers - provided a 360-degree view of the manufacturing challenges we must solve together. 

Brian O'Connor | VP Global Quality, Orchard Therapeutics, UK
Brian O'Connor
VP Global Quality
Orchard Therapeutics UK

Thanks for the invite. The conference was really excellent, due to the caliber and engagement of the attendees. 

Alvaro Avivar-Valderas | Associate Director - Cell Therapy Technology & Product Engine, Takeda, Spain
Alvaro Avivar-Valderas
Associate Director - Cell Therapy Technology & Product Engine
Takeda Spain

Thanks for putting this together! I enjoyed the discussions, atmosphere and engagement of participants. Great to be there!

Speaker Headshot BWD2026 Steffen Schulze 2
Steffen Schulze
Strategic Analytics & Business Analytics Lead
Roche Switzerland

I thoroughly enjoyed attending the CGT Manufacturing DACH 2026 by IMAPAC. The program featured exceptionally industry-relevant talks that provided deep insights into the current landscape. Beyond the sessions, the networking opportunities were top-tier, thanks to the high caliber of participants. 

merck200
Terry Gray
Field Marketing Manager
Merck

I had the pleasure of collaborating with the IMAPAC team during the Irish leg of the Biologics World event in February 2026. The organisers were exceptionally receptive and helpful, ensuring a seamless experience throughout the planning, exhibition logistics, partnering sessions, and sponsor visibility. Their proactive approach in connecting us with potential partners significantly enhanced our ROI. We are already exploring future opportunities to work with the IMAPAC team.

BioUK2026_SPEAKER_Dr Warren Roche
Warren Roche
Senior Statistical Expert
Sanofi Ireland

Thank you for your email and organising this wonderful event. It was a pleasure to participate. Congratulations on organising this event. It was a wonderful opportunity to present our work and to collaborate with others in the area. Looking forward to your next event 

BWD2026 Website Headshot Speaker Michael Inglis 2
Michael Inglis
Head of Manufacturing Sciences, Analytical Technologies
Chiesi Farmaceutici Global Rare Disease Ireland

Thank you, it was a pleasure meeting you, and your enthusiasm made it an engaging and positive event.

I hope we have opportunity to connect again in the future.

Speaker Headshot BWI2026 Shada Warreth 2
Shada Warreth
Global Partnerships Implementation Senior Manager
NIBRT Ireland

 Well done on a very informative and successful event.

 

TICKETS
free_ticket_mockup_london_biomanuk26_bp_website.4564ec01ff01
From £699 + VAT
free_ticket_mockup_london_biomanuk26_ssp_website.144dadbd20be
From £2895 + VAT

VENUE

Radisson Blu Hotel, London Heathrow

140 Bath Road, Harlington, Hayes UB3 5AW, UK
Getting There Accommodation Options View the Floorplan

Travel Options

Travel options Radisson Blu Hotel, London Heathrow 140 Bath Road, Hayes, Middlesex, UB3 5AW
We look forward to welcoming you to our event at the Radisson Blu Hotel, conveniently located just minutes from Heathrow Airport. Please find travel guidance below to help you plan your journey. 
subway.286a621e9981

By London Underground

Take the London Underground Piccadilly Line toward Heathrow Airport.

  • Alight at Heathrow Terminal 2 & 3 Underground Station
  • From the station, the hotel is a short taxi or bus journey away

Estimated travel time: 45–60 minutes from central London.

bus.092fa764c07e

From Heathrow Airport

The hotel is located along Bath Road, with regular bus services connecting all terminals.

  • Local bus routes: 105, 111, 140, 285
  • Hotel Hoppa shuttle service also available
  • Alight on Bath Road, a short walk from the hotel

Estimated travel time: 10–20 minutes

taxi_2.75bc650d90cf

Taxi or Ride-Hailing

Taxis and ride-hailing services are readily available at all Heathrow terminals.

Estimated travel time: 5–10 minutes Estimated cost: £10–£20

car.e22d1548067f

By Car

The hotel is easily accessible by road:

  • Address: 140 Bath Road, Hayes, Middlesex, UB3 5AW
  • Located just off the M4 motorway
On-site parking is available at the hotel
train_2.c46ac37e7110

From Other UK Cities

For guests travelling from outside London:

  • Arrive at London Paddington Station
  • Continue via:
    • Heathrow Express (fastest option), or
    • Elizabeth line (cost-effective alternative)
  • Transfer to bus or taxi for the final leg

Accommodation Options

Explore recommended hotels near the venue.

Exclusive delegate hotel rate

Please note: the conference registration fee does not include hotel accommodation or travel expenses.

IMAPAC has secured an exclusive discounted room rate for conference delegates. Use one of the booking options below and quote the conference block code where applicable.

Please complete your booking by 03 October 2026 to secure the discounted conference rate. Bookings made after the cut-off date are subject to hotel availability and may be charged at the prevailing room rate.

Standard Double Room

  • Single occupancy£129.00
  • Double occupancy£139.00

Rates include full breakfast.

Call the Radisson Blu Hotel, London Heathrow at +44 (0)20 8759 6311 and quote the block code “BIOF021126”.

Option 2 – By Email

Email the Radisson Blu Hotel, London Heathrow Reservations Team at reservations.heathrow@radissonblu.com
and quote the block code “BIOF021126”.

Email Hotel
Radisson Blu Hotel, London Heathrow Venue Hotel Special Rate

Radisson Blu Hotel, London Heathrow

140 Bath Road, Hayes, Middlesex, UB3 5AW
venue for this event

 To book a room at this hotel, please click the button below 

Book a Room
accom 2

London Heathrow Mariott Hotel

Bath Road Heathrow, Airport, Hayes UB3 5AN
4 minute walk from venue

 To book a room at this hotel, please click the button below 

Book a Room
accom 3

Ibis Style London Heathrow Airport

272 Bath Rd, London UB3 5AY
8 minute walk from venue

 To book a room at this hotel, please click the button below 

Book a Room
accom 4

Premier Inn London Heathrow

15 Bath Rd, London TW6 2AB
5 minute drive from venue

 To book a room at this hotel, please click the button below 

Book a Room
Event venue floorplan

Virtual Tour of Commonwealth Suite Virtual Tour of the Atrium Virtual Tour of Royal Suite
Please find the booth allocation in the table below.
3 Briggs of Burton 4 Alfa Laval 7 Greenfield Global 11 QuickSTAT 12 BSP Pharmaceuticals 14 AsTec Chemicals 17 Unchained Labs 19 Inprocess LSP 18 Kemwell Biopharma